Table 3 Summary of participants
From: Patients’ quality of life during active cancer treatment: a qualitative study
n (%) | |
|---|---|
Gender, women | 17 (57) |
Age, mean y | 63,5 |
30–40 | 3 (10) |
40–50 | 5 (17) |
50–60 | 6 (20) |
60–70 | 9 (30) |
≥ 70 | 7 (23) |
Cancer type | |
Breast carcinoma | 9 (30) |
Lung carcinoma | 1 (3) |
Melanoma | 7 (23) |
Skin lymphoma | 6 (20) |
Bladder/kidney carninoma | 3 (10) |
Prostate carcinoma | 1 (3) |
Testis germ cell cancer | 1 (3) |
Ovaries | 2 (7) |
Disease stage | |
Metastatic | 14 (47) |
Localized | 16 (53) |
Treatment recieved | |
Intravenous chemotherapy only | 6 (20) |
Intravenous chemotherapy + others | 19 (63) |
Oral chemotherapy, other treatments | 5 (17) |
Duration of cancer treatment period | |
Less than 1 year | 6 (20) |
1 to 3 years | 6 (20) |
3 to 5 years | 12 (40) |
More than 5 years | 6 (20) |
Recruitment site | |
Paris St Louis Hospital | 15 (50) |
Bobigny, Avicenne Hospital | 3 (10) |
Caen, university hospital centre | 12 (40) |